Back to Search

ALLAN SEIBERT, MD

MD

Pulmonary Disease Physician

NPI: 1801872353IndividualAccepts Medicare

Specialties, Licenses & Credentials

Critical Care Medicine (Internal Medicine) Physician

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

11004(AL)
Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

11004(AL)

CMS Specialties

PrimaryPULMONARY DISEASE

Additional

CRITICAL CARE (INTENSIVISTS)

Education

UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE

Class of 1982

Research & Publications (10)

Arg-14 loop of site 3 anemone toxins: effects of glycine replacement on toxin affinity.
PMID 14661964·Biochemistry·2003
7-preclinical
Feasibility and acceptance of electronic quality of life assessment in general practice: an implementation study.
PMID 19493355·Health Qual Life Outcomes·2009
8-other
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
PMID 19381015·J Clin Invest·2009
8-other
Computer-assisted image analysis of bronchioloalveolar carcinoma.
PMID 15845178·Clin Lung Cancer·2005
6-review
Differential phospholipid binding by site 3 and site 4 toxins. Implications for structural variability between voltage-sensitive sodium channel domains.
PMID 15632158·J Biol Chem·2005
8-other
Role of Asn-16 and Ser-19 in anthopleurin B binding. Implications for the electrostatic nature of Na(V) site 3.
PMID 15170345·Biochemistry·2004
4-observational
Separation of plutonium and neptunium species by capillary electrophoresis-inductively coupled plasma-mass spectrometry and application to natural groundwater samples.
PMID 14670034·Anal Chem·2003
8-other
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
PMID 12851279·JAMA·2003
3-trial
Voltage-gated sodium channel toxins: poisons, probes, and future promise.
PMID 12777715·Cell Biochem Biophys·2003
6-review
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
PMID 11700399·Crit Care Med·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 3 locations total

Address
8725 COUNTY ROAD 64
DAPHNE, AL 36526

Locations (3)

Practice Location

8725 COUNTY ROAD 64, DAPHNE, AL
(251) 625-1370

Practice Location

5955 AIRPORT BLVD, MOBILE, AL
(251) 633-0573

Practice Location

141 TUSCALOOSA ST., MOBILE, AL
(251) 433-3344

Quick Facts

NPI
1801872353
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
3
Years in Practice
44
Publications
10

Are you this provider?

Claim Your Profile